Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04-6790
- First Online:
Accumulating evidence suggests a potential role for the 5-HT6 receptor in cognitive function and the potential use of 5-HT6 receptor antagonists in the treatment of learning and memory disorders.
The aim of the current study was to investigate the effect of the selective 5-HT6 receptor antagonist, Ro 04-6790, on both the performance of normal adult rats and restoration of a pharmacological disruption of memory function produced by the non-selective muscarinic receptor antagonist, scopolamine, or the dopamine D2 receptor antagonist, raclopride, in a rodent model of recognition memory.
Passive, perceptually based, recognition memory was assessed using a novel object discrimination task. Following habituation to an arena, rats were presented with two identical objects during trial 1 (T1) and a novel and familiar object during trial 2 (T2). The time spent exploring the two objects in each trial was measured and novel object discrimination assessed in T2.
In the absence of drug all rats spent an equal time exploring the two identical objects in T1 but more time exploring the novel object in T2. Scopolamine (but not N-methylscopolamine) and raclopride both produced a dose-dependent reduction in novel object discrimination whilst the 5-HT6 receptor antagonist, Ro 04-6790, had no effect on discrimination when given alone but completely reversed the scopolamine- but not the raclopride-induced deficit.
This study demonstrates that acute administration of Ro 04-6790 reverses a cholinergic but not a dopaminergic deficit in a rodent model of recognition memory and provides further support for a role of the 5-HT6 receptor in the regulation of cognitive function.
KeywordsMemory Rats Ro 04-6790 5-HT6 receptor antagonists
- Aggleton JP, Keen S, Warburton EC, Bussey TJ (1997) Extensive cytotoxic lesions involving both the rhinal corticies and are TE impair recognition but spare alternation in the rat. Brain Res Bull 43:279–287Google Scholar
- Ainge JA, Heron-Maxwell C, Wright PG, de Hoz L, Wood ER (2002) Comparison of complete and partial lesions in rats on spontaneous object recognition and spatial water maze performance. Soc Neurosci Abstr 585.5Google Scholar
- Bentley JC, Sleight AJ, Marsden CA, Fone KCF (1997) 5-HT6 antisense oligonucleotide ICV affects rat performance in the water maze and feeding. J Psychopharmacol 11:A64Google Scholar
- Bentley JC, Marsden CA, Sleight AJ, Fone KCF (1999b) Effect of the 5-HT6 antagonist, Ro 04-6790 on food consumption in rats trained to a fixed feeding regime. Br J Pharmacol 126:66PGoogle Scholar
- Bromidge SM, Brown AM, Clarke SE, Dodgson K, Gager T, Grassam HL, Jeffrey PM, Joiner GF, King FD, Middlemiss DN, Moss SF, Newman H, Riley G, Routledge C, Wyman P (1999) 5-Chloro-N-(methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophene-sulfonamide (SB-271046): a potent, selective and orally bioavailable 5-HT6 receptor antagonist. J Med Chem 42:202–205Google Scholar
- Dunnett SB (1985) Comparative effects of cholinergic drugs and lesions of the nucleus basalis or fimbria-fornix on delayed matching in rats. Psychopharmacology 87:357–363Google Scholar
- Feldman RS, Meyer JS, Quenzer LF (1997) Catecholamines: In: Principles of neuropsychopharmacology. Sinauer, Sunderland, Mass., pp 277–344Google Scholar
- Harder JA, Kelly ME, Cheng CHK, Costall B (1996) Combined pCPA and muscarinic antagonist treatment produced a deficit in rat water maze acquisition, Pharmacol Biochem Behav 55:61–65Google Scholar
- Issac M, Slassi A, Xin T, Maclean N, Wilson J, McCallum K, Wang H, Demchyshyn L (2000) 6-Bicyclopiperazinyl-1-arylsulfonylindoes and 6-Bicyclopiperidinyl-1-arylsufony-lindoles derivatives as novel, potent, and selective 5-HT6 receptor antagonists. Bioorg Med Chem Lett 10:1719–1721CrossRefPubMedGoogle Scholar
- Lee M, Ragisetty JB, Dukat M, Slassi A, Maclean N, Lee DKH, Glennon RA (2000) 5-HT6 serotonin receptor bindings affinities of N1-benzenesulfonyl and related tryptamines. Med Chem Res 10:230–242Google Scholar
- Mostafa R, Ennaceur A (2001) Fornix lesions impair both spatial and non-spatial memory in rats: space vs. featureless objects. Eur J Neurosci 12:252SGoogle Scholar
- Ni J-W, Nakato K, Morita T, Okada, M, Yamaguchi T (2001) Acetylcholinesterase inhibitors improve aged rats' memory performance in object recognition. Soc Neurosci Abstr 27:P212Google Scholar
- Otano A, Frechilla D, Cobreros A, Cruz-Orive LM, Insausti A, Insausti R, Hamon M, Rio JD (1999) Anxiogenic-like effects and reduced stereological counting of immunolabelled 5-hydroxytryptamine6 receptors in rat nucleus accumbens by antisense oligonucleotides. Neuroscience 92:1001–1009CrossRefPubMedGoogle Scholar
- Rogers DC, Robinson TL, Quilter CA, Hunter AJ, Routledge C, Hagan JJ (1999) Cognitive enhancement effects of the selective antagonist SB-271046. Br J Pharmacol 121:22PGoogle Scholar
- Rogers DC, Hatcher PD, Hagan JJ (2000) The selective 5-HT6 receptor antagonist, SB-271046-A enhances performance of maze tasks in the rat. Soc Neurosci Abstr 26:680Google Scholar
- Roth BL, Craigo SC, Choudhary MS, Ulver A, Monsma FJ Jr, Shen Y, Meltzer HY, Sibley DR (1994) Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther 263:1403–1410Google Scholar
- Routledge C, Price GW, Bromidge SM, Moss SF, Newman H, Riley G, Gager T, Brown A M, Lighowler S, Middlemiss DN (1999) Characterization of SB-271046: a potent and selective 5-HT6 receptor antagonist. Br J Pharmacol 121:21PGoogle Scholar
- Shirazi-Southall S, Rodriguez DE, Nomikos GG (2002) Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. Neuropsychopharmacology 26:583–594Google Scholar
- Slassi A, Edwards L, O'Brien A, Xin T, Tehim A (2000) Preparation of 1-(arylsulfonyl)-3-(tetrahydropyridinyl)indoles as 5-HT6 receptor inhibitors. US Patent 6:133:287Google Scholar
- Sleight AJ, Consolo S, Martin JR, Boes M, Boess FG, Bentley JC, Bourson A (1999) 5-HT6 receptors: functional correlates and potential therapeutic indications. Behav Pharmacol 10:S86Google Scholar
- Stean TO, Hirst WD, Thomas DR, Price GW, Rogers D, Riley G, Bromidge SM, Serafinowska HT, Smith DR, Bartlett S, Deeks N, Duxon M, Upton N (2002) Pharmacological profile of SB-357134: a potent, selective, brain penetrant, and orally active 5-HT6 receptor antagonist. Pharmacol Biochem Behav 71:645–654CrossRefPubMedGoogle Scholar
- Vogt IR, Shimron-Abarbanell D, Neidt H, Erdmann J, Cichon S, Schulze TG, Muller DJ, Maier W, Albus M, Borrmann-Hassenbach M, Knapp M, Reitschel M, Propping P, Nothen MM (2000) Investigation of the human serotonin 6 (5-HT6) receptor gene in bipolar affective disorder and schizophrenia. Am J Med Genet 96:217–221CrossRefPubMedGoogle Scholar
- Woods ER, Phillips AG (1991) Deficits on a one trial object recognition task by rats with hippocampal CA1 lesions produced by cerebral ischemia. Neurosci Res Commun 9:177–182Google Scholar
- Woolley ML, Marsden CA, Sleight AJ, Fone KCF (2000) Co-localisation of 5-HT6 receptors on GABAergic but not cholinergic neurones in the adult rat brain. Brain Res Bull :94Google Scholar